LYEL
Price
$11.36
Change
+$0.04 (+0.35%)
Updated
Aug 8, 10:30 AM (EDT)
Capitalization
220.16M
TYRA
Price
$10.39
Change
-$0.36 (-3.35%)
Updated
Aug 8, 10:53 AM (EDT)
Capitalization
571.66M
83 days until earnings call
Interact to see
Advertisement

LYEL vs TYRA

Header iconLYEL vs TYRA Comparison
Open Charts LYEL vs TYRABanner chart's image
Lyell Immunopharma
Price$11.36
Change+$0.04 (+0.35%)
Volume$241
Capitalization220.16M
Tyra Biosciences
Price$10.39
Change-$0.36 (-3.35%)
Volume$200
Capitalization571.66M
LYEL vs TYRA Comparison Chart in %
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYEL vs. TYRA commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a Hold and TYRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (LYEL: $11.46 vs. TYRA: $10.75)
Brand notoriety: LYEL and TYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 29% vs. TYRA: 37%
Market capitalization -- LYEL: $220.16M vs. TYRA: $571.66M
LYEL [@Biotechnology] is valued at $220.16M. TYRA’s [@Biotechnology] market capitalization is $571.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileTYRA’s FA Score has 1 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • TYRA’s FA Score: 1 green, 4 red.
According to our system of comparison, TYRA is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 5 TA indicator(s) are bullish while TYRA’s TA Score has 4 bullish TA indicator(s).

  • LYEL’s TA Score: 5 bullish, 4 bearish.
  • TYRA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LYEL is a better buy in the short-term than TYRA.

Price Growth

LYEL (@Biotechnology) experienced а -2.96% price change this week, while TYRA (@Biotechnology) price change was -1.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.22%. For the same industry, the average monthly price growth was +6.60%, and the average quarterly price growth was +12.79%.

Reported Earning Dates

TYRA is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+0.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TYRA($572M) has a higher market cap than LYEL($220M). LYEL YTD gains are higher at: -10.469 vs. TYRA (-22.662). TYRA has higher annual earnings (EBITDA): -113.17M vs. LYEL (-204.02M). TYRA has more cash in the bank: 319M vs. LYEL (301M). TYRA has less debt than LYEL: TYRA (6.12M) vs LYEL (48.9M). LYEL has higher revenues than TYRA: LYEL (65K) vs TYRA (0).
LYELTYRALYEL / TYRA
Capitalization220M572M38%
EBITDA-204.02M-113.17M180%
Gain YTD-10.469-22.66246%
P/E RatioN/AN/A-
Revenue65K0-
Total Cash301M319M94%
Total Debt48.9M6.12M799%
TECHNICAL ANALYSIS
Technical Analysis
LYELTYRA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BVPIX23.140.08
+0.35%
Baywood ValuePlus Institutional
TOECX40.82N/A
N/A
Touchstone Mid Cap Growth C
GSTOX19.06N/A
N/A
Goldman Sachs Small Cap Gr Insghts Inv
QASGX27.17N/A
N/A
Federated Hermes MDT Small Cap Growth A
FRIQX12.10N/A
N/A
Fidelity Advisor Real Estate Income M

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
+3.43%
VCYT - LYEL
46%
Loosely correlated
+15.48%
CRBU - LYEL
41%
Loosely correlated
-3.72%
BEAM - LYEL
40%
Loosely correlated
-2.40%
ZNTL - LYEL
38%
Loosely correlated
+2.84%
TYRA - LYEL
37%
Loosely correlated
-2.54%
More

TYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TYRA has been loosely correlated with NRIX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TYRA jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TYRA
1D Price
Change %
TYRA100%
-2.54%
NRIX - TYRA
46%
Loosely correlated
-3.63%
AURA - TYRA
45%
Loosely correlated
-1.21%
DYN - TYRA
43%
Loosely correlated
-3.45%
RGNX - TYRA
42%
Loosely correlated
-4.01%
CRNX - TYRA
41%
Loosely correlated
-2.28%
More